Approvals/NMPA/Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation

Approved

化学药品

Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation

Novartis Pharma Schweiz AG🇨🇳 National Medical Products Administration

Approval Id: 888fe107LTE
Approval Number: 国药准字HJ20170391
Generic Name: 茚达特罗格隆溴铵吸入粉雾剂
Generic Name En: Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation
Trade Name: 杰润
Brand Name: 杰润
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每粒含马来酸茚达特罗110μg（按C₂₄H₂₈N₂O₃计）和格隆溴铵50μg（按C₁₉H₂₈NO₃计），每粒的递送剂量为马来酸茚达特罗85μg（按C₂₄H₂₈N₂O₃计）和格隆溴铵43μg（按C₁₉H₂₈NO₃计）
Reg Date: 2025-03-25
Expired Date: 2030-03-24
Company Name: Novartis Pharma Schweiz AG
Production Company Name: SIEGFRIED BARBERA S.L.
Company Detail Path: /organization/novartis-pharma-schweiz-ag
Production Company Detail Path: /organization/siegfried-barbera-s-l

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 25, 2025

Approval ID

888fe107LTE

Type

化学药品